Commercial launch of OXPEKK® Custom Compounds of proprietary poly-ether-ketone-ketone (PEKK) formulations


Oxford Performance Materials, Inc. (OPM), a leader in advanced materials science and high performance additive manufacturing (HPAM™), announced the commercial launch of OXPEKK® Custom Compounds.
OXPEKK products are comprised of OPM’s family of proprietary poly-ether-ketone-ketone (PEKK) formulations.  With the commercial launch of OXPEKK Custom Compounds, OPM is addressing critical unmet needs in key markets including the medical, aerospace, automotive, electronics, energy, and semiconductor industries. “OXPEKK is a special breed of polymer with a desirable combination of processing and performance attributes that address some of the most demanding applications in today’s industrial markets,” stated Tony DeCarmine, OPM’s Chief Technology Officer. “We are very excited to be launching OXPEKK Custom Compounds, which offer a unique combination of properties that users of high performance polymers will find compelling.” Key performance characteristics of OPM’s OXPEKK Custom Compounds include:

* Robust mechanical performance
* Extreme temperature tolerance
* High purity
* Gamma stability
* Exceptionally high chemical resistance
* Resistance to water or solvent infiltration
* Superior fatigue performance

OPM utilizes advanced processing technologies to manufacture OXPEKK Custom Compounds in pellet form and extruded semi-finished shapes.  The OXPEKK product lines offer several advantages over metals and other thermoplastics in process flexibility, reduced weight, non-corrosive attributes, and tailored formulations, including filled and colored compounds. 

Product Certification
All OPM products are supported by the highest level of testing and certification.  For the biomedical market, the OXPEKK Custom Compound product portfolio includes OXPEKK®-MG (Medical Grade for non-implant applications) and OXPEKK®-IG (Implant Grade for implantable devices), both subject to strict regulatory standards:
OXPEKK Custom Compounds for medical use have been tested against ISO 10993standards, demonstrating safe use in permanent implant applications with bone and tissue contact;
OXPEKK Custom Compounds are produced in a controlled cGMP environment supported by a robust Quality Management System (QMS).

Manufacturing & Facility
The OXPEKK Custom Compounding facility utilizes state-of-the-art compounding technology supported by a full material science and quality control lab.  All OPM facilities are designed to meet key regulatory requirements:

ISO 13485 certification for medical applications with a QMS intended to address applicable Medical Device Directives (MDD), regulations and responsibilities, demonstrating a commitment to the safety and quality of the medical devices manufactured by OPM customers;

AS9100C certification for aerospace & industrial applications when OXPEKK Custom Compounds are subject to elevated risk management standards in those markets.

  More News  Post Your Comment

Previous News

Next News

{{comment.Name}} made a post.




There are no comments to display. Be the first one to comment!


Name Required.


Email Id Required.

Email Id Not Valid.


Mobile Required.

Email ID and Mobile Number are kept private and will not be shown publicly.

Message Required.

Click to Change image  Refresh Captcha